Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
about
Clinical utility of the risperidone formulations in the management of schizophrenia.Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalization.The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics.Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases.Management of schizophrenia in late life with antipsychotic medications: a qualitative review.Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.Patterns of Antipsychotic Prescribing by Physicians to Young Children.Participation in daily life of people with schizophrenia in comparison to the general population.Extrapyramidal Symptoms Probably Related to Risperidone Treatment: A Case Series.Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report.The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample.Magnesium Supplementation Prevents and Reverses Experimentally Induced Movement Disturbances in Rats: Biochemical and Behavioral Parameters.Parsing the components of the psychomotor syndrome in schizophrenia.
P2860
Q30429721-7379DB00-2E1D-4B18-A985-13DDCC93055DQ33718170-264A2ED1-49B2-4F90-948B-A63CEB062115Q33770747-E3C1CD04-EFC1-4155-BA87-E7A4D292A130Q34388086-C4779228-C86C-4D1D-B5D1-D875D8CCB8BCQ34522634-0E5A3BB0-9E4C-464B-BCE7-E70AC08BCEDEQ34693244-97CADA55-877B-4010-8FF6-7B32FD981746Q37960898-65B2099E-3978-4CF6-9319-4D23B0FC9DBAQ38032249-B40C022B-57DF-4C1A-965C-EC8C4AB66817Q38473914-820BAE47-ADB7-4030-B830-307AA858806DQ38545655-A11ADB28-1135-4AE4-BDCD-9AEE0C2B5339Q39600765-BF07082B-5077-4D38-BD44-A53ECB11B485Q39721120-45066876-07A9-4C76-ABB1-9A03F5DC56A8Q41485699-E2949C1E-6A04-4E1D-B5AD-C0B68D3692C9Q42050098-56A775BD-E6A0-451F-9944-E53BFCDD5A10Q42251217-AE2FE46F-067D-4391-8405-283126F1A6E9Q42348171-5E78A866-683A-4D57-92F4-DE3C1669E64DQ42495794-2F8F186B-7BE0-4ED7-A49E-5038AF4A9C05Q46771862-62A61272-C2F0-4FBA-BE79-3782243EA25FQ48724316-5EAF94EF-93DA-4063-99BB-6BEB7DC1EAAC
P2860
Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Incidence of extrapyramidal sy ...... patient health outcomes study.
@en
Incidence of extrapyramidal sy ...... patient health outcomes study.
@nl
type
label
Incidence of extrapyramidal sy ...... patient health outcomes study.
@en
Incidence of extrapyramidal sy ...... patient health outcomes study.
@nl
prefLabel
Incidence of extrapyramidal sy ...... patient health outcomes study.
@en
Incidence of extrapyramidal sy ...... patient health outcomes study.
@nl
P1476
Incidence of extrapyramidal sy ...... patient health outcomes study.
@en
P2093
Jordan Bertsch
Peter M Haddad
P304
P356
10.1097/JCP.0B013E3181F14098
P407
P577
2010-10-01T00:00:00Z